EMBCV - embecta to Participate in Upcoming Investor Conferences in September
PARSIPPANY, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences:
The 2022 Wells Fargo Healthcare Conference at the Encore Boston Harbor Hotel in Boston, Mass.
- Management will participate in a fireside chat on Thursday, September 8 at 8:00 a.m. Eastern Time.
The 20 th Annual Global Healthcare Conference at the Sheraton New York, N.Y.
- Management will participate in a fireside chat on Tuesday, September 13 at 2:55 p.m. Eastern Time.
Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com .
About embecta
embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com .
CONTACTS
Investors:
Pravesh Khandelwal
VP, Head of Investor Relations
551-264-6547
Contact IR
Media:
Christian Glazar
Sr. Director, Corporate Communications
908-821-6922
Contact Media Relations